Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 701–800 of 1,035
Bidulescu, A., Liu, J., Hickson, D. A., Hairston, K. G., Fox, E. R., Arnett, D. K., Sumner, A. E., Taylor, H. A., & Gibbons, G. H. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-9 · Cited by 85
“The negative correlation between adiponectin and VAT is stronger than with SAT [28, 29].”
BackgroundBorel, A.-L., Coumes, S., Reche, F., Ruckly, S., Pépin, J.-L., Tamisier, R., Wion, N., & Arvieux, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0206617 · Cited by 71
Glintborg, D., Andersen, M., Richelsen, B., & Bruun, J. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03523.x · Cited by 78
Friedenreich, C. M., Neilson, H. K., O’Reilly, R., Duha, A., Yasui, Y., Morielli, A. R., Adams, S. C., & Courneya, K. S. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2239 · Cited by 76
“The median (interquartile range) intense exercise time according to heart rate monitors (excluding the ramp-up period) was 88 (53115) and 128 (66-185) min/wk for the moderate- and highvolume groups, respectively, representing 59% and 43% of prescribed durations.”
BackgroundAdvancing targeted protein degradation for metabolic diseases therapy
Zhou, Q., Xiao, H., Yang, F., Wang, Y., Li, P., & Zheng, Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106627 · Cited by 78
State of the art papers Dietary and nutraceutical approach to type 2 diabetes
Derosa, G., Limas, C. P., Macías, P. C., Estrella, A., & Maffioli, P. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.42587 · Cited by 70
“In recent years, several studies have shown that obesity may cause cardiovascular disease through different mechanisms such as sub-clinical inflammation, endothelial dysfunction, increase in sympathetic tone, atherogenic lipid profile, thrombogenic factors and obstructive sleep apnea [4].”
BackgroundPharma–nutrition interface: The gap is narrowing
Georgiou, N., Garssen, J., & Witkamp, R. F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.007 · Cited by 91
Ding, J., Kritchevsky, S. B., Hsu, F.-C., Harris, T. B., Burke, G. L., Detrano, R. C., Szklo, M., Criqui, M. H., Allison, M., Ouyang, P., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.645 · Cited by 75
“It is postulated that inability of subcutaneous fat deposition to buffer the energy excess results in accumulation of non-subcutaneous fat deposition (also termed ectopic fat deposition) around and within the heart, liver, and skeletal muscle, and excess non-subcutaneous fat deposition then impairs the functions of su…”
BackgroundLiu, Z., Zhou, X., Wang, W., Gu, L., Hu, C., Sun, H., Xu, C., Hou, J., & Jiang, Z. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07884 · Cited by 77
Burton, J. O., Gray, L. J., Webb, D. R., Davies, M. J., Khunti, K., Crasto, W., Carr, S. J., & Brunskill, N. J. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr574 · Cited by 77
“It is generally recognized that the central deposition of fat (abdominal or visceral obesity) is closely associated with chronic diseases and is a key constituent of the metabolic syndrome [15, 16].”
BackgroundNyberg, A., Saey, D., & Maltais, F. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201505-278ps · Cited by 88
The Role of T Cells in Obesity-Associated Inflammation and Metabolic Disease
Park, C., & Shastri, N. (2022) · Immune Network · doi:10.4110/in.2022.22.e13 · Cited by 88
Spolidoro, J. V., Filho, M. L. P., Vargas, L. T. R., Santana, J. C. B., Pitrez, E. H., Hauschild, J. A., Bruscato, N. M., Moriguchi, E. H., Medeiros, A. K., & Piva, J. P. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.05.020 · Cited by 92
Koch, E. S., Bogado, M. E., Araya, F., Romero, T. E., Díaz, C., Manríquez, L., Paredes, M., Román, C., Taylor, A., & Kirschbaum, A. (2008) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2007.062240 · Cited by 77
“These findings are important because regional obesity has been associated with the majority of obesity-related metabolic complications.(43) Whether parity exerts any protective role in the distribution of adipose tissue in women is a conjecture that requires further investigation using a prospective design.”
BackgroundKullberg, J., Johansson, L., Ahlström, H. K., Courivaud, F., Koken, P., Eggers, H., & Börnert, P. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21820 · Cited by 77
Ding, L., Li, J., Song, B., Xu, X., Huang, W., Zhang, B., Tang, X., Qi, M., Yang, Q., Yang, Q., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217968 · Cited by 91
“It is characterized by an excessive increase in adipose tissue mass and dysregulation of lipid metabolism (Després and Lemieux, 2006).”
BackgroundT-Cell Costimulation Protects Obesity-Induced Adipose Inflammation and Insulin Resistance
Zhong, J., Rao, X., Braunstein, Z., Taylor, A., Narula, V., Hazey, J., Mikami, D., Needleman, B., Rutsky, J., Sun, Q., et al. (2014) · Diabetes · doi:10.2337/db13-1094 · Cited by 73
“3 INTRODUCTION Inflammation is widely believed to play a key pathogenic role in the development of obesity-induced insulin resistance (IR) and type 2 diabetes (1-3).”
BackgroundKim, S.-H., Chung, J.-H., Song, S.-W., Jung, W. S., Lee, Y.-A., & Kim, H.-N. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0127-7 · Cited by 72
“Although visceral adipose tissue (VAT) has been recognized as a key determinant of MS and is presumed to play an important role in its development [2, 3], the role of subcutaneous adipose tissue (SAT) is not well understood.”
BackgroundZhang, L., Han, Y., Zhang, X., Wang, X., Bao, B., Qu, W., & Liu, J. (2016) · Diabetologia · doi:10.1007/s00125-016-4039-8 · Cited by 87
Wittmann, K., Sieber, C., von Stengel, S., Kohl, M., Freiberger, E., Jakob, F., Lell, M., Engelke, K., & Kemmler, W. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s116430 · Cited by 73
Jomaa, L., Naja, F., Cheaib, R., & Hwalla, N. C. (2017) · BMC Public Health · doi:10.1186/s12889-017-4317-5 · Cited by 89
“Elevated WC have been found to be associated with visceral adipose tissue [37], and it was used in the present study given the strong evidence that correlates abdominal fat with a higher risk of metabolic diseases, including diabetes, metabolic syndrome, and cardiovascular diseases [38, 39].”
BackgroundMeasures of Adiposity and Risk of Stroke in China: A Result from the Kailuan Study
Wang, A., Wu, J., Zhou, Y., Guo, X., Luo, Y., Wu, S., & Zhao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061665 · Cited by 78
“It has been recognized that BMI does not distinguish subjects with excess adiposity tissue from those with high muscle mass; therefore, this characteristic may incorrectly reflect the risk of stroke for subjects with high muscle mass [19,20,21].”
BackgroundAndroid and gynoid fat percentages and serum lipid levels in U nited S tates adults
Min, K., & Min, J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12505 · Cited by 83
Liu, Z., Zhao, J., Sun, R., Wang, M., Wang, K., Li, Y., Shang, H., Hou, J., & Jiang, Z. (2022) · Food & Function · doi:10.1039/d1fo04316a · Cited by 79
Zhang, L., Gonçalves, C. M. V., Dai, L., Lü, H., Huang, J., Ji, H., Wang, D., Yi, L., & Liang, Y. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.04.008 · Cited by 77
“Metabolic syndrome (MetS) is a complex disorder associated with insulin resistance, obesity, hyperglycemia, dislipidemia and hypertension [1–4].”
BackgroundOverweight, obesity and related non-communicable diseases in Asian Indian girls and women
Chopra, S. M., Misra, A., Gulati, S., & Gupta, R. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.70 · Cited by 90
High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan
Chang, H. H., Chou, C. H., Chen, P. S., Gean, P. W., Huang, H. C., Lin, C. Y., Yang, Y. K., & Lu, R. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.018 · Cited by 82
Kring, S. I. I., Holst, C., Zimmermann, E., Jess, T., Berentzen, T. L., Toubro, S., Hansen, T. F., Astrup, A. V., Pedersen, O. B., & Sørensen, T. I. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002958 · Cited by 87
“This finding was expected because fatness is inversely correlated with insulin sensitivity [26].”
BackgroundUngru, J., Coenen, M., Vervuert, I., Blüher, M., Raila, J., & Boston, R. (2012) · Veterinary Record · doi:10.1136/vr.100911 · Cited by 76
“…adipokines, such as RBP4 or leptin, or downregulated adipokines, such as adiponectin may impair insulin signalling and upregulate inflammatory cytokines which, additionally, contribute to impaired insulin signalling and endothelial dysfunction (Després and Lemieux 2006, Radin and others 2009).”
BackgroundExcessive visceral fat accumulation in advanced chronic obstructive pulmonary disease
Kida, K., Furutate, R., Ishii, I., Wakabayashi, Motegi, Yamada, & Gemma (2011) · International Journal of COPD · doi:10.2147/copd.s22885 · Cited by 82
“Visceral adiposity is generally associated with adipocyte dysfunction, leading to systemic inflammation.(33) In a previous study, adipocyte dysfunction was found to be associated with adipose tissue hypoxia.”
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Ramírez, B., Silva, C., Rotellar, F., Hernández-Lizoáin, J. L., Baixauli, J., Valentí, V., Pardo, F., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.015 · Cited by 81
“Inflammation is independently linked with VAT expansion [52].”
BackgroundJia, Y., Hong, J., Li, H., Hu, Y., Jia, L., Cai, D., & Zhao, R. (2017) · Experimental Physiology · doi:10.1113/ep086114 · Cited by 71
“Obesity is considered a worldwide public health crisis, leading to insulin resistance and cardiovascular disease (Weiss et al. 2004; Despres & Lemieux, 2006; Ritchie & Connell, 2007).”
BackgroundChen, X., Zhuo, S., Zhu, T., Yao, P., Yang, M., Mei, H., Li, N., Ma, F., Wang, J. M., Chen, S., et al. (2019) · Diabetes · doi:10.2337/db18-0469 · Cited by 79
“Obesity is a major risk factor for the development of insulin resistance and type 2 diabetes (1,2).”
BackgroundA review on molecular mechanism of alcoholic liver disease
Namachivayam, A., & Gopalakrishnan, A. V. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119328 · Cited by 78
Shin, J., Toyoda, S., Nishitani, S., Fukuhara, A., Kita, S., Otsuki, M., & Shimomura, I. (2021) · Diabetes · doi:10.2337/db20-1094 · Cited by 77
“In patients with older age, obesity, and diabetes (1), hyperinsulinemia (2) causes cellular stress and induces the XBP-1-mediated overexpression of GRP78 (3) in adipose tissue, which promotes the localization of GRP78 to the circulation (4) and cell surface (5), not only to ER (6).”
BackgroundMetabolically Active Human Brown Adipose Tissue Derived Stem Cells
Silva, F. J., Holt, D. J., Vargas, V., Yockman, J. W., Boudina, S., Atkinson, D. L., Grainger, D. W., Revelo, M. P., Sherman, W., Bull, D. A., et al. (2014) · Stem Cells · doi:10.1002/stem.1595 · Cited by 81
“resistance, metabolic syndrome and cardiovascular disease [2].”
Cornelissen, P. L., Tovee, M. J., & Bateson, M. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.09.041 · Cited by 80
“Abdominal adiposity is assumed to reflect individual differences in physiology orthogonal to total body fat (Després and Lemieux, 2006), and has consequently been argued to be useful in predicting a range of health and fertility outcomes (Hu et al.”
Janković, A., Korać, A., Srdić, B., Buzadžić, B., Otašević, V., Stančić, A., Vučetić, M., Markelic, M. B., Veličković, K., Golić, I., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.01.009 · Cited by 76
“expanded waist or waist/hip circumference ratio, is a better marker of obesity-associated metabolic complications than is obesity per se [5,6].”
BackgroundInvestigation of the Anti-Obesity Action of Licorice Flavonoid Oil in Diet-Induced Obese Rats
Kamisoyama, H., Honda, K., TOMINAGA, Y., Yokota, S., & HASEGAWA, S. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.80469 · Cited by 75
Waist Circumference, BMI, and Visceral Adipose Tissue in White Women and Women of African Descent
Sumner, A. E., Micklesfield, L. K., Ricks, M., Tambay, A. V., Avila, N. A., Thomas, F., Lambert, E. V., Levitt, N. S., Evans, J., Rotimi, C. N., et al. (2011) · Obesity · doi:10.1038/oby.2010.201 · Cited by 69
“Yet in blacks and whites, VAT is etiologically related to insulin resistance, dyslipidemia, and inflammation; all features of cardiovascular disease, type 2 diabetes mellitus, and the metabolic syndrome (6,8,9).”
BackgroundAdipose Insulin Resistance in Obese Adolescents Across the Spectrum of Glucose Tolerance
Hershkop, K., Besor, O., Santoro, N., Pierpont, B., Caprio, S., & Weiss, R. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1376 · Cited by 72
“Although intra-abdominal fat has been shown not to contribute a greater proportion of systemic FFAs in relation to its share of total fat (30), it may be the source of other mediators having a mechanistic role in the development of systemic IR (16, 31).”
BackgroundEndocrinology, energetics, and human life history: A synthetic model
Ellison, P. T. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.09.006 · Cited by 80
“cortisol action and thus be associated with redistribution of fat rather than loss of fat 206 (Despres and Lemieux, 2006).”
BackgroundValidity of visceral adiposity estimates from DXA against MRI in Kuwaiti men and women
Mohammad, A., Rolfe, E. D. L., Sleigh, A., Kivisild, T., Behbehani, K., Wareham, N. J., Brage, S., & Mohammad, T. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2016.38 · Cited by 75
Belligoli, A., Compagnin, C., Sanna, M., Favaretto, F., Fabris, R., Busetto, L., Foletto, M., Prà, C. D., Serra, R., Prevedello, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47719-y · Cited by 81
Association between coronary atherosclerosis and visceral adiposity index
Bagyura, Z., Kiss, L. Z., Lux, Á., Csobay-Novák, C., Jermendy, Á. L., Polgár, L., Szelid, Z., Soós, P., & Merkely, B. P. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.01.013 · Cited by 79
van Dijk, T. H., Laskewitz, A. J., Grefhorst, A., Boer, T. S., Bloks, V. W., Kuipers, F., Groen, A. K., & Reijngoud, D. (2013) · Laboratory Animals · doi:10.1177/0023677212473714 · Cited by 79
Harada, K., Baba, Y., Ishimoto, T., Kosumi, K., Tokunaga, R., Izumi, D., Ida, S., Imamura, Y., Iwagami, S., Miyamoto, Y., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4432-4 · Cited by 77
Compartmental neck fat accumulation and its relation to cardiovascular risk and metabolic syndrome
Torriani, M., Gill, C. M., Daley, S. M., Oliveira, A. L., Azevedo, D. C., & Bredella, M. A. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.088450 · Cited by 74
Vongsuvanh, R., George, J., McLeod, D. J., & van der Poorten, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.013 · Cited by 82
“Clearly, dyslipidemia is important in atherogenesis and in scoring systems that include both WC and triglycerides – such as VAI itself and the hypertriglyceridemic waist phenotype [32,33], both of which are strongly correlated with cardiovascular risk.”
BackgroundThe Utility of Physical Activity in the Management of Global Cardiometabolic Risk
Janiszewski, P. M., & Ross, R. (2009) · Obesity · doi:10.1038/oby.2009.382 · Cited by 70
Haufe, S., Haas, V., Utz, W., Birkenfeld, A. L., Jeran, S., Böhnke, J., Mähler, A., Luft, F. C., Schulz-Menger, J., Boschmann, M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0102 · Cited by 72
“Increases in visceral and subcutaneous abdominal fat as well as ectopic fat deposition contribute to the development of metabolic abnormalities in obesity (1).”
BackgroundTreating the metabolic syndrome
Bianchi, C., Penno, G., Romero, F., Prato, S. D., & Miccoli, R. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.3.491 · Cited by 83
Glucocorticoid Modulation of Insulin Signaling in Human Subcutaneous Adipose Tissue
Gathercole, L. L., Bujalska, I. J., Stewart, P. M., & Tomlinson, J. W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1399 · Cited by 73
“Whilst it is plausible that this may have an impact upon insulin sensitivity in distant organs including liver and muscle (44), sc adipose tissue deposition per se may not always be detrimental and indeed may be protective form some of the adverse consequences of obesity (45).”
BackgroundUpdated survey of the steroid-converting enzymes in human adipose tissues
Tchernof, A., Mansour, M. F., Pelletier, M., Boulet, M.-M., Nadeau, M., & Luu-The, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.011 · Cited by 73
“fact, abdominal–visceral obesity is recognized as the most prevalent manifestation of the metabolic syndrome, and certainly represents an essential feature of the current obesity epidemic [8,17].”
Synthetic therapeutic gene circuits in mammalian cells
Ye, H., & Fussenegger, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.003 · Cited by 76
“Metabolic syndrome is a primary, epidemic public health challenge in the 21st century that is characterised by the three interlinked and interdependent metabolic disorders of hypertension, hyperglycemia, and obesity [43,44].”
BackgroundEpicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?
Christensen, R. H., von Scholten, B. J., Lehrskov, L. L., Rossing, P. R., & Jørgensen, P. G. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820928824 · Cited by 75
Metabolic Consequences of Solid Organ Transplantation
Bhat, M., Usmani, S. E., Azhie, A., & Woo, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa030 · Cited by 80
Sobolewska-Nowak, J., Wachowska, K., Nowak, A., Orzechowska, A., Szulc, A., Płaza, O., & Gałecki, P. (2023) · Biomedicines · doi:10.3390/biomedicines11071903 · Cited by 84
Komori, T., Tanaka, M., Senba, E., Miyajima, A., & Morikawa, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.461905 · Cited by 72
“It has been most widely accepted that obesity is a major risk factor for the development of insulin resistance (1), which is followed by hyperinsulinemia, the exhaustion of pancreatic FIGURE 8.”
BackgroundViljanen, A. P. M., Lautamäki, R., Järvisalo, M., Parkkola, R., Huupponen, R., Lehtimäki, T., Rönnemaa, T., Raitakari, O. T., Iozzo, P., & Nuutila, P. (2009) · Annals of Medicine · doi:10.1080/07853890802446754 · Cited by 70
“as part of a cluster of metabolic abnormalities defined as a metabolic syndrome (34).”
BackgroundYang, F., Wang, G., Wang, Z., Sun, M., Cao, M., Zhu, Z., Fu, Q., Mao, J., Shi, Y., & Yang, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104365 · Cited by 79
“Arnlöv et al. [33] have shown that overweight and obese men without metabolic syndrome (MetS) have an increased risk of CVD during a 30-year follow-up.”
BackgroundInfluentialRecent advances in metabolic syndrome and cardiovascular disease
Guize, L., Pannier, B., Thomas, F., Bean, K., Jégo, B., & Bénétos, A. (2008) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.06.011 · Cited by 73
“Several studies have suggested that the impact of certain combinations of metabolic syndrome components are more deleterious than others, such as abdominal obesity and elevated TGs [40—42].”
BackgroundLong‐TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat
Lundbom, J., Hakkarainen, A., Söderlund, S., Westerbacka, J., Lundbom, N., & Taskinen, M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1580 · Cited by 70
“overnutrition and a sedentary lifestyle (2).”
Bredella, M. A., Gill, C. M., Keating, L., Torriani, M., Anderson, E. J., Punyanitya, M., Wilson, K. E., Kelly, T. L., & Miller, K. K. (2013) · Obesity · doi:10.1002/oby.20424 · Cited by 79
“Visceral adiposity is a major risk factor for the development of the metabolic syndrome and is associated with insulin resistance, dyslipidemia, and a proinflammatory and prothrombotic state (1-3).”
BackgroundMeasurement of Visceral Fat: Should We Include Retroperitoneal Fat?
Hung, C., Lee, J., Yang, C., Hsieh, H.-R., Ma, W.-Y., Lin, M., Liu, P., Shih, S., Liou, J., Chuang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112355 · Cited by 78
“In addition, the free fatty acid flux from abdominal adipose tissue to the liver results in disturbances in glucose and lipid metabolism [4], which contribute to the development of insulin resistance and dyslipidemia in participants with MS [5].”
BackgroundFeng, H., Zhang, S., Wan, J. M., Gui, L., Ruan, M., Li, N., Zhang, H., Liu, Z., & Wang, H. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.07.086 · Cited by 75
Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3
Cheng, C., Ku, H., Cheng, J., Chao, S.-W., Li, H., Lai, P., Chang, C., Don, M., Chen, H.-H., & Lin, H. (2019) · Communications Biology · doi:10.1038/s42003-019-0624-y · Cited by 85
Kim, G., Yoon, Y., Park, J., Park, J. W., Noh, M., Kim, H., Park, C.-H., Kwon, H., Park, J. H., Kim, Y., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01374-0 · Cited by 74
Predicting Metabolic Syndrome in Obese Children and Adolescents: Look, Measure and Ask
Santoro, N., Amato, A., Grandone, A., Brienza, C., Savarese, P., Tartaglione, N., Marzuillo, P., Perrone, L., & del Giudice, E. M. (2013) · Obesity Facts · doi:10.1159/000348625 · Cited by 74
Abdominal Fat in Children Measured by Ultrasound and Computed Tomography
Mook‐Kanamori, D. O., Holzhauer, S., Hollestein, L. M., Durmuş, B., Manniesing, R., Koek, M., Boehm, G., van der Beek, E. M., Hofman, A., Witteman, J. C. M., et al. (2009) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2009.07.002 · Cited by 83
“The ratio between visceral and subcutaneous fat is significantly associated with several metabolic risk factors (Faria et al. 2002; Despres and Lemieux 2006).”
BackgroundConsensus statement on diagnosis and clinical management of Klinefelter syndrome
Radicioni, A. F., Ferlin, A., Balercia, G., Pasquali, D., Vignozzi, L., Maggi, M., Foresta, C., & Lenzi, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03350351 · Cited by 77
“In addition, the adipose tissue produces adipokines that are implicated in the pathogenesis of dyslipidemia, IR, and MetS (58).”
BackgroundNadler, E. P., Reddy, S., Isenalumhe, A., Youn, H. A., Peck, V., Ren, C. J., & Fielding, G. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.07.022 · Cited by 73
Chaput, J., McNeil, J., Després, J., Bouchard, C., & Tremblay, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072832 · Cited by 78
“type 2 diabetes, is a critical public health problem nowadays [16].”
BackgroundSelf-citationInflammation, neoangiogenesis and fibrosis in peritoneal dialysis
de Lima, S. M. A., Otoni, A., Sabino, A. D. P., Dusse, L. M. S., Gomes, K. B., Pinto, S. W. L., Marinho, M. A. S., & Rios, D. R. A. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.027 · Cited by 76
Kim, S.-J., Chae, S., Kim, H., Mun, D., Back, S., Choi, H. Y., Park, K. S., Hwang, D., Choi, S. H., & Lee, S. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035501 · Cited by 75
“Moreover, higher amounts of VATs are commonly observed in patients with metabolic diseases and other ectopic fat deposition (13, 17).”
BackgroundRed-fleshed sweet orange juice improves the risk factors for metabolic syndrome
da Silveira, J. Q., Dourado, G. K. Z. S., & Cesar, T. B. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1093610 · Cited by 80
“Furthermore, among individuals with excess weight, those with metabolic syndrome present lower serum antioxidant levels when compared with individuals without metabolic syndrome (Després & Lemieux, 2006; Pizent et al., 2010; Reitman et al., 2002).”
BackgroundBrækkan, S. K., Hald, E. M., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Rosendaal, F. R., & Hansen, J. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237545 · Cited by 72
Visceral adiposity in gastrointestinal and hepatic carcinogenesis
Vongsuvanh, R., George, J., Qiao, L., & van der Poorten, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.038 · Cited by 74
“Visceral adipose tissue (VAT) is thought to modulate a range of systemic and end-organ effects through the release of adipocytokines, growth factors and inflammatory mediators [6].”
BackgroundFigueroa, A. L., Takx, R. A. P., MacNabb, M. H., Abdelbaky, A., Lavender, Z. R., Kaplan, R. S., Truong, Q. A., Lo, J., Ghoshhajra, B. B., Grinspoon, S. K., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004043 · Cited by 77
“One possible theory is that excess energy is primarily stored in SAT; however, when this depot is dysfunctional, energy can alternatively be stored in VAT.(38) In the Framingham Heart Study, VAT/SAT ratio was found to significantly correlate with cardiometabolic risk factors, beyond associations with BMI and VAT.”
BackgroundInfluentialMarrow adipose tissue spectrum in obesity and type 2 diabetes mellitus
de Araújo, I. M., Salmón, C. E. G., Nahas, A. K., Nogueira‐Barbosa, M. H., Elías, J., & de Paula, F. J. A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0448 · Cited by 72
Ortiz, J. B., & Conrad, C. D. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.005 · Cited by 81
Kolben, Y., Weksler‐Zangen, S., & Ilan, Y. (2020) · Obesity Reviews · doi:10.1111/obr.13108 · Cited by 77
“lar complications, which increase the risk of cardiovascular diseases (CVD) and type 2 diabetes (T2D).(1) The pathogenesis of MetS involves”
BackgroundImplication of hepatokines in metabolic disorders and cardiovascular diseases
Jung, T. W., Yoo, H. J., & Choi, K. M. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.03.002 · Cited by 71
“Obesity-associated lipolysis induces the release of free fatty acids into the blood stream [3] and increases subclinical inflammation, thereby aggravating insulin resistance in various tissues [4].”
BackgroundLatouche, C., Heywood, S. E., Henry, S. L., Ziemann, M., Lazarus, R. M., El‐Osta, A., Armitage, J. A., & Kingwell, B. A. (2013) · Journal of Nutrition · doi:10.3945/jn.113.186775 · Cited by 76
Zhou, J., Zhang, N., Aldhahrani, A., Soliman, M. M., Zhang, L., & Zhou, F. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956688 · Cited by 82
“According to reports, puerarin has a certain therapeutic effect on hypertension, diabetes, arteriosclerosis, and other diseases in diabetic rats (22, 23).”
BackgroundSenger, A. E. V., Schwanke, C. H. A., Gomes, I., & Gottlieb, M. G. V. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0081-5 · Cited by 76
Duan, X., Xie, P., Ma, Y., & Tang, S. (2010) · Amino Acids · doi:10.1007/s00726-010-0800-3 · Cited by 71
Lear, S. A., Chockalingam, A., Kohli, S., Richardson, C. G., & Humphries, K. H. (2012) · Obesity · doi:10.1038/oby.2011.395 · Cited by 71
“Despite being a relatively small adipose depot (VAT only accounts for ~20% and 10% of total body fat in men and women, respectively (25,26)), VAT has been demonstrated to be more strongly associated with a number of risk factors than generalized obesity (27,28).”
BackgroundBartelt, A., Orlando, P., Mele, C., Ligresti, A., Toedter, K., Scheja, L., Heeren, J., & Marzo, V. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2274-6 · Cited by 71
“Since hypertrophic adipose tissue mass is associated with an increased risk of developing insulin resistance, dyslipidaemia and cardiovascular disease [35], interest has increased in deciphering factors linking lipid metabolism directly or indirectly with insulin signalling.”
BackgroundBorel, A.-L., Leblanc, X., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Després, J.-P., & Series, F. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201001 · Cited by 69
Self-citationNg, J. M., Azuma, K., Kelley, C., Pencek, R., Radikova, Z., Laymon, C., Price, J., Goodpaster, B. H., & Kelley, D. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00282.2012 · Cited by 67
“In addition, studies in our laboratory have shown that subcutaneous thigh AT mass either did not associate with IR or is positively associated with higher systemic insulin sensitivity (1, 8, 11).”
BackgroundOxytocin Reverses Ovariectomy-Induced Osteopenia and Body Fat Gain
Beranger, G. E., Pisani, D. F., Castel, J., Djedaini, M., Battaglia, S., Amiaud, J., Boukhechba, F., Ailhaud, G., Michiels, J.-F., Heymann, D., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1688 · Cited by 67
Russo, C. A., Sera, F., Jin, Z., Palmieri, V., Homma, S., Rundek, T., Elkind, M. S. V., Sacco, R. L., & Tullio, M. R. D. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.521 · Cited by 75
Wang, Y., Chen, D., Zhang, Y., Wang, P., Zheng, C., Zhang, S., Yu, B., Zhang, L., Zhao, G., Ma, B., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032398 · Cited by 73
Nutrition, Bioenergetics, and Metabolic Syndrome
García‐García, F. J., Monistrol-Mula, A., Cardellach, F., & Garrabou, G. (2020) · Nutrients · doi:10.3390/nu12092785 · Cited by 87
“This situation is caused by the inability of adipose tissue to store the energy excess, so the FFA overload is accumulated in the muscle, heart, liver, or as subcutaneous fat [102].”
BackgroundRazavi, R., Parvaresh, A., Abbasi, B., Yaghoobloo, K., Hassanzadeh, A., Mohammadifard, N., Clark, C. C. T., & Morteza Safavi, S. (2021) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000623 · Cited by 66
Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema
Matsuo, K., Mandelbaum, R. S., Matsuzaki, S., Klar, M., Roman, L. D., & Wright, J. D. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.12.1213 · Cited by 70
Ungvari, Z. I., Fekete, M., Varga, P., Lehoczki, A., Fekete, J. T., Ungvari, A., & Győrffy, B. (2024) · GeroScience · doi:10.1007/s11357-024-01375-x · Cited by 74
“Furthermore, it also contributes to the pathogenesis of various other age-related diseases driven by inflammation, such as atherosclerosis [98, 113, 115, 118, 123–131].”
Godin, O., Leboyer, M., Gaman, A., Aouizerate, B., Berna, F. S., Brunel, L., Capdevielle, D., Chéreau, I., Dorey, J., Dubertret, C., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.047 · Cited by 77
“7 mM or on lipid lowering medication) and high waist circumference (N94 cm for males and N80 cm for females) (Despres and Lemieux, 2006; Girerd et al., 2009).”
BackgroundAnalysis of systemic and airway inflammation in obstructive sleep apnea
Aihara, K., Oga, T., Chihara, Y., Harada, Y., Tanizawa, K., Handa, T., Hitomi, T., Uno, K., Mishima, M., & Chin, K. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0726-y · Cited by 72
“In particular, visceral adipose tissue accumulation may contribute to systemic inflammation by releasing numerous cytokines [17, 18].”
Background
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.